Eli Lilly's stock rose after the FDA approved their new oral weight loss pill, Zepbound, which is expected to be popular and accessible.
Source Post
Stock Market Weekly! - NVIDIA Buying New AI Stock 🤑 Sandisk Soaring 📈Nike Earnings 📉 Tesla Demand 📉
This week's stock market update covers a broad range of individual stock news and market movements. Key highlights include Nvidia's investment in Marvell Technology, Tesla's disappointing Q1 delivery numbers, Nike's weak earnings and guidance, a rally in memory chip stocks like Micron and SanDisk following concerns about Google's new AI technology, and Eli Lilly's FDA approval for a new weight loss pill. The creator also touches on the broader market's rally despite geopolitical tensions and discusses the potential impact of inflation and interest rates on the economy.
Linked Mentions
Tickers discussed in this post
Micron, along with other memory chip stocks, saw a rally due to the Jevons paradox potentially increasing demand for memory chips and geopolitical factors favoring US-based producers.
Nike's stock fell sharply after reporting weak forward guidance, with expected revenue drops and significant declines in Chinese sales, leading to a cautious outlook.
Tesla's Q1 delivery numbers missed expectations, raising concerns about slowing demand and inventory build-up, despite the creator's long-term bullish thesis on future ventures.
Marvell Technology is benefiting from a deepening partnership with Nvidia, which invested in the company to collaborate on AI infrastructure.
Nvidia's investment in Marvell Technology is seen as a strategic move to deepen their partnership in AI-centric infrastructure, strengthening Nvidia's market position and moat.